Basal and postprandial levels of ghrelin and the nature of eating behaviour in patients with irritable bowel syndrome with constipation against the background of various degrees of obesity
Journal Title: Сучасна гастроентерологія - Year 2018, Vol 0, Issue 4
Abstract
Objective — to study the basal and postprandial serum levels of ghrelin, its association with types of eating behaviour and the appearance of constipation in patients with irritable bowel syndrome against the background of obesity. Materials and methods. The investigation of blood serum levels of ghrelin involved 10 healthy subjects with normal body weight and 50 patients. In compliance with the Rome criteria IV, the diagnosis of irritable bowel syndrome with constipation (IBSc) against the background of normal body mass was established in 18 patients (BMI — 19.7 ± 0.4 kg/m2), and in 32 subjects IBSc on the background of different stages of obesity (12 — I degree, BMI — 33.0 ± 0.4, 12 — II degrees, BMI — 37.9 ± 0.3 and 8 — III degrees, BMI — 42.6 ± 0.5 kg/m2). In all subjects, the ghrelin levels were determined in fasting blood and one hour after eating by using of the Ray Biotech Human Grelin kits. At the same time, in all surveyed subjects the type of eating behaviour (EB) was established with the use of the Dutch Eating Behaviour Questionnaire (DEBQ). Results. In has been established that in IBSc patients, the serum ghrelin levels in fasting blood was 2.1 times lower than in healthy subjects, and an hour after meals, the ghrelin level dropped in 2.7 times, while patients with IBSc only tended to decrease. In the patients with IBSc and obesity, the ghrelin levels in fasting blood were reduced in 1.8 times in patients with obesity of I degree, in 4.2 times at II degree and in 11.5 in case of III degree. In opposite to healthy subjects, the postprandial ghrelin levels in patients with IBSc and obesity, increased in 1.5; 2.1 and 2.7 times depending on the degree of obesity. The emotional type of EB was established in 56.25 % of patients with comorbid pathology. The probability of the development of constipation was the highest in patients with an emotional type of EB (OR — 24.43; p = 0.001) and lower in external EB (OR — 9.95; p = 0.04). Conclusions. The absence of the ghrelin levels’ reduction after meals in patients with irritable bowel syndrome against the obesity background was defined as a motivational factor for repeated episodes of eating. Its effects on the eating behaviour and stress (emotional and external to the type of eating behaviour) increased the constipations’ formation.
Authors and Affiliations
V. G. Mischuk, G. V. Grigoruk
Keywords
Related Articles
- EP ID EP417396
- DOI 10.30978/MG-2018-3-30
- Views 125
- Downloads 0
The role and place of Actovegin in the complex therapy of cytokine metabolism in patients with GERD with concomitant bronchial asthma
Objective — to study the advisability of the Actovegin inclusion in the standard treatment regimen for patients with GERD and concomitant mild to moderate BA in terms of its effects on the clinical course of this comorbi...
Changes in the microcrystallization of oral fluid in the dynamics of treatment of catarrhal gingivitis in adolescents with chronic gastroduodenitis
Objective — to study the changes of microcrystallization of saliva in adolescents with chronic gastroduodenitis in the process of complex treatment of generalized catarrhal gingivitis. Materials and methods. The type of...
Helicobacter pylori infection and acid-related diseases against the background of metabolic-associated conditions: mechanisms of development and management
The author presents data on the role of H. pylori infection in the initiation and progression of the changes in metabolic status of patients with type 2 diabetes mellitus (DM-2), insulin resistance, obesity, cardiovascul...
The evaluation of frequency and character of hepatotoxic reactions in patients with acute myeloid leukemia in the dynamics of remission induction
Objective — to study the frequency and character of liver functional disturbances in patients with acute myeloid leukemia (AML) depending on the morphologic variant according to the FAB-classification and prescribed che...
A place of plasma substitutes in the treatment of patients with chronic viral hepatitis
Objective — to assess the efficacy of plasma substitute (Reosorbilact) in patients with chronic viral hepatitis. Materials and methods. The investigation involved 60 patients with chronic viral hepatitis (CVH), who were...